Rheumatoid factor: Difference between revisions

From IDWiki
(Created page with "== Background == * Anti-IgG IgM antibody Category:Rheumatology Category:Investigations")
 
 
(3 intermediate revisions by the same user not shown)
Line 1: Line 1:
 
== Background ==
 
== Background ==
   
  +
* General class of IgM antibodies to the Fc region of IgG
−
* Anti-IgG IgM antibody
 
  +
*Most asymptomatic people with positive RF do ''not'' progress to [[rheumatoid arthritis]]
  +
*Neither specific nor sensitive for [[RA]]
  +
  +
== Differential Diagnosis ==
  +
  +
* Rheumatic disorders
  +
** [[Rheumatoid arthritis]] (26-90%)
  +
**[[Systemic lupus erythematosus]] (15-35%), [[Sjögren syndrome]] (75-95%), and [[mixed connective tissue disorder]] (50-60%)
  +
** Type II and III [[cryoglobulinemia]] (40-100%)
  +
** [[Polymyositis]] and [[dermatomyositis]] (5-10%)
  +
* Chronic infections
  +
** Bacterial [[endocarditis]] (25-50%)
  +
** [[Hepatitis B]] and [[hepatitis C]] (20-75%)
  +
** Other viruses, such as [[HIV]], [[Epstein-Barr virus]], and [[CMV]]
  +
** Some parasites, including [[malaria]], [[schistosomiasis]], and [[toxoplasmosis]]
  +
* Inflammatory disorders
  +
** [[Cirrhosis]] (25%)
  +
** [[Primary biliary cirrhosis]] (45-70%)
  +
** [[Idiopathic pulmonary fibrosis]] (10-50%)
  +
** [[Sarcoidosis]] (3-33%)
  +
** [[Silicosis]] and [[asbestosis]] (30-50%)
  +
* Malignancies
  +
** B-cell disorders (5-25%)
  +
* Normal aging
  +
** ≥65 years of age (5-25%)
  +
  +
== Further Reading ==
  +
  +
* Rheumatoid Factors: Clinical Applications. ''Dis Markers''. 2013;35(6):727–734. doi: [https://doi.org/10.1155/2013/726598 10.1155/2013/726598]
   
 
[[Category:Rheumatology]]
 
[[Category:Rheumatology]]

Latest revision as of 06:39, 27 March 2022

Background

  • General class of IgM antibodies to the Fc region of IgG
  • Most asymptomatic people with positive RF do not progress to rheumatoid arthritis
  • Neither specific nor sensitive for RA

Differential Diagnosis

Further Reading

  • Rheumatoid Factors: Clinical Applications. Dis Markers. 2013;35(6):727–734. doi: 10.1155/2013/726598